Ledger.Open graph →
SEC Form D · filed March 30, 2017

Gemphire Therapeutics Inc

Offering
$12.5M
Sold
$12.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LIVONIA, MI
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Steve K. Gullans · Boston, MADirectorP. K. Hawryluk · Carmel, INDirectorAndy Sassine · Rancho Santa Fe, CADirectorPedro K. Lichtinger · New York, NYDirectorJeffrey K. Mathiesen · Livonia, MIExecMina Sooch · Livonia, MIExec · DirectorCharles Bisgaier · Ann Arbor, MIExec · DirectorKenneth Kousky · Freeland, MIDirectorSeth K. Reno · Livonia, MIExecDeborah L. Machovec · Wahoo, NEDirectorVanessa Barrett · Grand Cayman, Cayman IslandsDirectorMichael T. Hearne · Dallas, TXDirectorUlf Lindskog · Uppsala, V7DirectorLee S. Golden · Livonia, MIExecGeorge A. Parris · Audubon, IADirectorAlan I. Bossin · Hamilton, BermudaDirectorAlexander F. Bayer · GREENWOOD VILLAGE, CODirectorNathan T. Kirkpatrick · Chicago, ILDirectorJeffrey K. Mathiesen · Livonia, MIExecLee S. Golden · Livonia, MIExecMina Sooch · Livonia, MIExec · DirectorCharles Bisgaier · Ann Arbor, MIExec · DirectorKenneth Kousky · Freeland, MIDirectorSeth K. Reno · Livonia, MIExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗